Seelos Therapeutics, Inc.
SEELDelisted Apr 4, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001017491
Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Seelos Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 110 | 1 | 97 | −12 |
| Shares | 40.8M | 72.4K | 40.5M | −245.1K (−0.6%) |
| Value | $98.2M | $174.0K | $65.9M | −$32.1M (−32.8%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Seelos Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Group One Trading, L.P. | 969,993 | $1.58M | 0.03% |
| AQR Capital Management LLC | 95,825 | $156.0K | 0.00% |
| Jane Street Group, LLC | 52,275 | $85.0K | 0.00% |
| Engineers Gate Manager LP | 50,790 | $83.0K | 0.00% |
| HRT Financial LP | 15,237 | $24.0K | 0.00% |
| Rinkey Investments | 3,500 | $5.00K | 0.00% |
| National Bank of Canada | 1,000 | $2.00K | 0.00% |
| TAP Consulting, LLC | 1,035 | $2.00K | 0.00% |
| Captrust Financial Advisors | 557 | $1.00K | 0.00% |
| Financial Advocates Investment Management | 24,673 | – | – |
| CoreCap Advisors, LLC | 100 | – | – |
Sold out (23)
Institutions that held Seelos Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
Not filed for Q4 2021 yet (1)
Institutions that held Seelos Therapeutics, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Knott David M | 72,367 | $174.0K |